Boston Scientific mum on reported Stryker takeover move

par Thomas Dworetzky, Contributing Reporter | June 12, 2018

Also in October, 2017, Boston Scientific agreed to acquire Apama Medical for $300 million.

The acquisition of the privately-held, California-based company will allow Boston Scientific to expand its electrophysiology portfolio, combining its radiofrequency point-by-point solution with Apama’s single-shot balloon ablation technology for the treatment of atrial fibrillation (AF).

Training and education based on your needs

Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money

“Single-shot pulmonary vein isolation (PVI) ablation is a high-growth market segment,” Joe Fitzgerald, president of rhythm management at Boston Scientific, told HCB News. “Our current electrophysiology (EP) portfolio includes a radiofrequency (RF) point-by-point solution, and the Apama technology, upon regulatory approval, will allow us to expand into the single-shot market segment, and ultimately bolster our entire EP portfolio.”

Back to HCB News



You Must Be Logged In To Post A Comment Se connecter Se você já criou uma conta, use seu endereço de e-mail e senha para entrar usando o formulário abaixo. Problèmes de connexion: Click here si vous rencontrez des problèmes de connexion. Adresse e-mail: Mot de passe: Mot de passe oublié ? Problèmes de connexion ? Voir notre « Mentions légales » et Notice de Confidentialité Registre L'inscription est gratuite et facile. Aproveite os benefícios dos principais produtos novos e inovadores do mundo. Mercado de equipamentos médicos usados. Inscrivez-vous maintenant !